Profiting from a rival's problems
DuPont's known for chemicals, but the company is seeing big market share gains in its seed business.
Shares of DuPont (DD) have been in slow retreat since the company announced third-quarter earnings Tuesday -- not because of anything the company reported, in my opinion, but because in the last week or so, we've moved into a "sell the news" reaction to just about all good earnings reports.
If that continues for a bit (and I'll try to define "a bit" at the end of this post), I think you'll get a chance to pick up the shares of a seed company that is taking advantage of troubles at competitor Monsanto (MON) for a very reasonable price.
For the quarter, DuPont reported earnings of 40 cents a share -- 6 cents above Wall Street consensus. Revenue grew by 14% from the third quarter of 2009 to $7 billion. Wall Street had projected revenue of $6.76 billion.
And DuPont raised guidance for the full year to $3.10 a share. That's above the $3.04 Wall Street consensus and the range of $2.90 to $3.05 in the company's previous guidance.
Not bad results, hey? Well, since then, the stock has slipped a bit, from $47.70 Monday to $47.03 on Thursday. I think that's a reflection of a general weakness in the market in the last few days and of some profit-taking in DuPont shares, which had climbed to a new 52-week high at $48.
What especially interests me in the shares -- beyond the company's expectations for continued strong demand from global markets in its chemicals business -- is the gains in market share reported for its seed business.
The company's seed business Pioneer Hi-Bred increased its market share in corn by three percentage points (to 35%) and by five percentage points (to 31%) in the soybean market.
Some of that gain comes thanks to disarray at competitor Monsanto, which very aggressively priced its most recent generation of seeds and then saw market push-back from farmers who didn't see the extra performance in the field to justify all of that higher price.
I'm putting this on my watch list, looking here for a slight further pull back to near the 50-day moving average at $44 a share. (That's my definition of "a bit"); I'd be a buyer near that price.
The shares currently trade at 13.7x trailing-12-month earnings per share. That's below the 14.7x multiple for the Standard & Poor's 500 and the five-year average price-to-earnings ratio of 15.5x for DuPont itself. And, by the way, the shares currently pay a dividend yield of 3.47%.
At the time of this writing, Jim Jubak didn't own shares of any companies mentioned in this post in personal portfolios. The mutual fund he manages, Jubak Global Equity Fund (JUBAX), may or may not own positions in any stock mentioned. For a full list of the stocks in the fund as of the end of the most recent quarter, see the fund's portfolio here.
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
3 stocks will be in the spotlight Thursday as investors try to make sense of the numbers from the sector.
VIDEO ON MSN MONEY
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.